Search Results 91-100 of 14827 for alt

1. A Study to Evaluate Pembrolizumab and Dasatinib, Imatinib Mesylate, or Nilotinib in Treating Patients with Chronic Myeloid Leukemia and Persistently- Detectable Minimal Residual Disease - Mayo Clinic

   AST (SGOT) and ALT (SGPT) ≤ 2.5 X ULN OR ≤ 5 X ULN for subjects with liver metastases. ALT: ______ Institutional ULN: ______ Date of Test: ______; AST ...

2. High red blood cell count Causes - Mayo Clinic

   Causes · Low oxygen levels · Blood cancers · Misuse of medical treatments to improve athletic performance · Other diseases · Higher red blood cell concentration.

3. A Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics Of AJ201 In Patients - Mayo Clinic

   the presence of elevated serum CK levels, ALT, or AST, up to 5 times the ULN are acceptable if other liver tests are normal. b. If the total bilirubin ...

4. Phase III DAS181 Lower Tract PIV Infection in Immunocompromised Subjects (Substudy: DAS181 for COVID-19): RCT Study - Mayo Clinic

   Note: Subjects with ALT/AST/ALP ≥ 3x ULN AND TB ≥2x ULN that have been chronically stable (for >1 year on more than one assessments) due to known liver ...

5. A Study to Evaluate the Effectiveness and Safety of Benralizumab in Patients with Hypereosinophilic Syndrome (HES) - Mayo Clinic

   ALT or AST level ≥ 3 × ULN during the screening period (AST or ALT \> 5 × ULN if documented HES with liver manifestations). Transient increase of AST/ALT ...

6. A Phase 3 Study of Efficacy and Safety of Remibrutinib in the Treatment of Chronic Spontaneous Urticaria in Adults Inadequately Controlled by H1-antihistamines - Mayo Clinic

   Aminotransferase (ALT) levels of more than 1.5 x upper limit of normal (ULN) or. International Normalized Ratio (INR) of more than 1.5 at screening. Note ...

7. MicroOrganoSphere Drug Screen Pilot Trial in Colorectal Cancer (CRC) - Mayo Clinic

   Hemoglobin ≥ 8 g/dL (transfusions are permitted to achieve baseline hemoglobin level);. ALT/AST (alanine aminotransferase (ALT) / aspartate aminotransferase ...

8. A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis) - Mayo Clinic

   * Alanine aminotransferase (ALT) or aspartate aminotransferase (AST) ≥250 units per liter (U/L) * Participants taking vitamin E (\>400 international units ...

9. A Study of Adjunctive Ganaxolone Treatment in Children and Young Adults with CDKL5 Deficiency Disorder - Mayo Clinic

   ... [ALT]) and hematology during the course of treatment, and is expected to remain constant throughout the double-blind phase. 10. Parent/caregiver is able and ...

10. Safety and Efficacy of Selonsertib in Adults With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis (NASH) - Mayo Clinic

    Alanine aminotransferase (ALT) ≤ 8 x upper limit of normal (ULN); Creatinine Clearance (CLcr) ≥ 30 milliliter/minute (mL/min), as calculated by the ...